Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra Two-Dose vs One-Dose Schedule in Children
NCT00700635Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Primary completion
- May 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of meningococcal A conjugate vaccine in meningococcal infection (3 arms), sponsored by Sanofi. Primary endpoint: Percentage of Participants With Meningococcal Antibody Titers ≥ 8 After Each Vaccination. Started Jun 2008; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00700635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700635.